Predictive role of γ-glutamyltransferase in patients receiving nivolumab therapy for metastatic renal cell carcinoma

被引：0
|
作者：
Yudai Ishiyama
Tsunenori Kondo
Hidekazu Tachibana
Hiroki Ishihara
Hironori Fukuda
Kazuhiko Yoshida
Toshio Takagi
Junpei Iizuka
Kazunari Tanabe
机构：
[1] Tokyo Women’s Medical University Medical Center East,Department of Urology
[2] Tokyo Women’s Medical University,Department of Urology
来源：
International Journal of Clinical Oncology | 2021年 / 26卷
关键词：
Metastatic kidney cancer; Biomarkers; Immunotherapy; Immune-checkpoint inhibitor; Prognosticator;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：552 / 561
页数：9
相关论文
共 50 条
  • [1] Predictive role of γ-glutamyltransferase in patients receiving nivolumab therapy for metastatic renal cell carcinoma
    Ishiyama, Yudai
    Kondo, Tsunenori
    Tachibana, Hidekazu
    Ishihara, Hiroki
    Fukuda, Hironori
    Yoshida, Kazuhiko
    Takagi, Toshio
    Iizuka, Junpei
    Tanabe, Kazunari
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (03) : 552 - 561
  • [2] Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab
    Catalano, Martina
    Rebuzzi, Sara Elena
    Maruzzo, Marco
    De Giorgi, Ugo
    Buti, Sebastiano
    Galli, Luca
    Fornarini, Giuseppe
    Zucali, Paolo Andrea
    Procopio, Giuseppe
    Chiellino, Silvia
    Milella, Michele
    Catalano, Fabio
    Pipitone, Stefania
    Ricotta, Riccardo
    Soraru, Mariella
    Mollica, Veronica
    Tudini, Marianna
    Fratino, Lucia
    Prati, Veronica
    Caffo, Orazio
    Atzori, Francesco
    Morelli, Franco
    Prati, Giuseppe
    Nole, Franco
    Vignani, Francesca
    Cavo, Alessia
    Di Napoli, Marilena
    Malgeri, Andrea
    Naglieri, Emanuele
    Signori, Alessio
    Banna, Giuseppe Luigi
    Rescigno, Pasquale
    Antonuzzo, Lorenzo
    Roviello, Giandomenico
    JAMA NETWORK OPEN, 2023, 6 (11) : E2345185
  • [3] Predictive factors for immediate progression after nivolumab therapy for metastatic renal cell carcinoma
    Kondo, Tsunenori
    Takagi, Toshio
    Tachibana, Hidekazu
    Ishihara, Hiroki
    Kobayashi, Hirohito
    Iizuka, Junpei
    Yoshida, Kazuhiko
    Toki, Daisuke
    Mizutani, Kazuo
    Tanabe, Kazunari
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 : 231 - 231
  • [4] Skeletal muscle density as a positive predictive factor for nivolumab therapy in patients with metastatic renal cell carcinoma.
    Ekenel, Meltem
    Sari, Murat
    Aliyev, Samil
    Basaran, Mert
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] Efficacy of axitinib in patients with metastatic renal cell carcinoma refractory to nivolumab therapy
    Yoshida, Kazuhiko
    Takagi, Toshio
    Kondo, Tsunenori
    Kobayashi, Hirohito
    Iizuka, Junpei
    Fukuda, Hironori
    Ishihara, Hiroki
    Okumi, Masayoshi
    Ishida, Hideki
    Tanabe, Kazunari
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (06) : 576 - 580
  • [6] Body composition in patients with metastatic renal cell carcinoma receiving ipilimumab plus nivolumab.
    Dzimitrowicz, Hannah Elizabeth
    Schwartz, Fides
    Infield, Jordan
    Zhang, Dylan
    Ho, Ethan
    Wu, Yuan
    Gupta, Rajan T.
    Harrison, Michael Roger
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16517 - E16517
  • [7] Potential biomarkers for nivolumab therapy of metastatic renal cell carcinoma
    Sayapina, M. S.
    Savyolov, N. A.
    Lyubimova, N. V.
    Timofeev, Yu. S.
    Nosov, D. A.
    ONKOUROLOGIYA, 2018, 14 (01): : 16 - 27
  • [8] CLINICAL IMPLICATIONS AND PREDICTIVE FACTORS OF PRIMARY RESISTANCE TO NIVOLUMAB PLUS IPILIMUMAB THERAPY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
    Numakura, Kazuyuki
    Hatakeyama, Shingo
    Sekine, Yuya
    Yumina, Muto
    Kobayashi, Mizuki
    Kashima, Soki
    Yamamoto, Ryohei
    Nara, Taketoshi
    Saito, Mitsuru
    Narita, Shintaro
    Ohyama, Chikara
    Habuchi, Tomonori
    JOURNAL OF UROLOGY, 2023, 209 : E371 - E372
  • [9] Nivolumab in metastatic renal cell carcinoma
    Nature Reviews Urology, 2015, 12 (2) : 63 - 63
  • [10] Predictive factors of nivolumab plus ipilimumab treatment efficacy in metastatic renal cell carcinoma patients
    Ohba, Kojiro
    Nakanishi, Hiromi
    Kawada, Ken
    Nakamura, Yuichiro
    Mitsunari, Kensuke
    Matsuo, Tomohiro
    Mochizuki, Yasushi
    Imamura, Ryoichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (07) : 827 - 832
12345